Salzman & Co’s Allergan plc AGN Stock Holding History

Salzman & Co’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-44,274	Closed	-$10.2M	–	5
2016 Q2	$10.2M	Buy	+44,274	New	+$10.2M	47.23%	1
2015 Q1	–	Sell	-30,782	Closed	-$7.92M	–	21
2014 Q4	$7.92M	Buy	30,782 +403	+1%	+$101K	1.77%	12
2014 Q3	$7.33M	Hold	30,379	–	–	1.76%	14
2014 Q2	$6.78M	Buy	+30,379	New	+$6.29M	2.2%	15

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Salzman & Co's AGN Position: Q3 2016 in Review

Salzman & Co sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 44,274 shares — an estimated $10.2M sold.

Salzman & Co first reported a position in AGN in Q2 2014 and held it in 4 quarters. The position peaked at $10.2M in Q2 2016. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

Salzman & Co reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
Salzman & Co sold 44,274 Allergan plc shares in Q3 2016, an estimated $10.2M.
Salzman & Co first reported a position in Allergan plc in Q2 2014 and held it in 4 quarters.
Salzman & Co's Allergan plc position peaked at $10.2M in Q2 2016.
1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Salzman & Co's 13F filing for Q3 2016, filed 14 Nov 2016.